Pharmafile Logo
Pharmafocus logo
Advanced Search
Lucentis image

NICE gives Lucentis more scope

November 27, 2013
Sales and Marketing Lucentis, NICE, Novartis, cnv

An undisclosed price cut from Novartis has been enough to swing NICE towards using the manufacturer’s Lucentis in a fourth …

News

Bayer targets Norway’s Algeta

November 27, 2013
Sales and Marketing Algeta, Bayer, oncology, xofigo

Bayer HealthCare is in the market to buy Norwegian oncology specialist Algeta. The German pharma group has made a bid …

News
catherine_dick_web_aesica

Aesica appoints new site manufacturing manager

November 27, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Aesica, catherine dick

Contract development and manufacturing organisation Aesica has appointed Catherine Dick to the role of site manufacturing manager. She will take …

Appointment
Gilead image

Gilead runs into India patent trouble

November 26, 2013
Sales and Marketing Gilead, MSF, hepc, sofosbuvir, sovaldi

Gilead Sciences has run into heavy traffic in India as campaigners attempt to block the company’s patent there on new …

News
dna image

Google diagnostic firm receives scathing FDA warning

November 26, 2013
Medical Communications, Research and Development, Sales and Marketing FDA, dna. 23andme, google

The Google-backed DNA testing firm 23andMe has received a warning letter from the FDA saying it cannot continue to market …

News
Unilife image

Hikma taps Unilife for pre-filled syringes

November 26, 2013
Manufacturing and Production Hikma, pre-filled, unilife

Jordanian drugmaker Hikma has signed a strategic-level deal with Unilife for the manufacture of generic injectable drugs using its pre-filled …

News

FDA U-turn on Avandia

November 26, 2013
Sales and Marketing Avandia, CDER, FDA, GSK, diabetes, nissen, type 2

The FDA has delivered a shock verdict that the stringent restrictions on GlaxoSmithKline’s diabetes medicine Avandia should be lifted, despite …

News
william_mcculloch

3-V Biosciences hires chief medical officer

November 26, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 3V, biosciences, mcculloch

Clinical-stage biopharma firm 3-V Biosciences has taken on Dr William McCulloch as its chief medical officer.  McCulloch brings nearly three …

Appointment
NHS image

PPRS deal ‘dreadful’, says EMIG

November 26, 2013
Sales and Marketing EMIG, NHS, NICE, PPRS, VBP

The Ethical Medicines Industry Group (EMIG) has slammed the new PPRS plan, calling it a ‘dreadful deal’ for its members. …

News
gsk image

GSK expands Montrose API plant with £25m investment

November 25, 2013
Manufacturing and Production GSK, Scotland, montrose

GlaxoSmithKline is planning to invest £25 million ($40m) at a facility in Scotland that will take on production of ingredients …

News
nexavar image

US regulator shows Nexavar green light

November 25, 2013
Sales and Marketing Bayer, Cancer, FDA, Nexavar, Onyx, thyroid

The FDA has extended the indication of liver and kidney cancer pill Nexavar to treat late-stage differentiated thyroid cancer. It …

News

Cancer Research UK invests £100m in research centres

November 25, 2013
Research and Development, Sales and Marketing Cancer, Cancer Research UK, UK

Cancer Research UK says it will invest over £100 million across 15 cutting-edge research centres to help get new treatments …

News
janssen image

FDA approves Olysio

November 25, 2013
Sales and Marketing FDA, Janseen, Janssen, hep C, hepc, olysio, simeprevir

US regulators have approved Janssen Pharmaceuticals’ Olysio, a new therapy to treat chronic hepatitis C virus infection, after a priority …

News

Patient involvement ‘increases public confidence’ in research

November 25, 2013
Research and Development, Sales and Marketing hra, mori, public, rec, research

A new study has shown that public confidence in health research studies can be increased by knowing that patients have …

News
talent_pipeline

Hold your horses: M&A is about talent, not just pipelines

November 25, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, mergers, molloy, roik, rsa, talent

The morning mist is rising on the battlefield. At stake: the crown riches and glory of tomorrow’s pharma leadership. The …

Feature

Camargo Pharmaceutical Services names chief operating officer

November 25, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Camargo Pharmaceutical Services

Veteran healthcare executive Jim Beach has been named chief operating officer for drug development firm Camargo Pharmaceutical Services. “Jim’s history …

Appointment

Gilead gets CHMP nod

November 25, 2013
Research and Development, Sales and Marketing CHMP, FDA, Gilead, chc, sovaldi

The CHMP has opened the way for Gilead Sciences’ first-in-class investigational chronic hepatitis C drug Sovaldi (sofosbuvir) to get to …

News

Pfizer says it will close Puerto Rico plant

November 22, 2013
Manufacturing and Production Guayama, Humacao, Pfizer, Puerto Rico, Vega Baja

News
NHS image

E-prescribing ‘patchy at best’

November 22, 2013
Medical Communications, Sales and Marketing DoH, NHS, UCL, e-prescribing

Electronic prescribing in NHS hospitals – seen as one of the cornerstones of public health provision in the future – …

News

Cancer app takes top prize in Janssen digital awards

November 22, 2013
Medical Communications, Sales and Marketing Cancer, J&J, JJ, app, digital, px healthcare

A start-up firm established by medical scientists that develops mobile apps for cancer patients has taken first place in the …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026